Established in early 2018, Uvax Bio is a vaccine company that originated as a spin-off from Scripps Research in La Jolla, CA. The company utilizes the patented single-component self-assembling protein nanoparticle (1c-SApNP) platform technology, developed by Professor Jiang Zhu at Scripps Research. Uvax Bio is dedicated to leveraging this innovative technology to create and bring to market B-cell focused, rapid antibody-elicit...
Established in early 2018, Uvax Bio is a vaccine company that originated as a spin-off from Scripps Research in La Jolla, CA. The company utilizes the patented single-component self-assembling protein nanoparticle (1c-SApNP) platform technology, developed by Professor Jiang Zhu at Scripps Research. Uvax Bio is dedicated to leveraging this innovative technology to create and bring to market B-cell focused, rapid antibody-eliciting, preventive vaccines targeted at addressing the most formidable diseases globally.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.